Back
iRadimed Quote, Financials, Valuation and Earnings
Buy
53
IRMD
iRadimed
Last Price:
41.93
Seasonality Move:
18.03%
7 Day Trial
ALL ACCESS PASS
$
7
iRadimed Price Quote
$41.93
-0.10 (-1.69%)
(Updated: May 18, 2024 at 5:46 AM ET)
iRadimed Key Stats
Buy
53
iRadimed (IRMD)
is a Buy
Day range:
$41.60 - $42.63
52-week range:
$36.12 - $51.04
Dividend yield:
0.71%
P/E ratio:
31.13
P/S ratio:
7.91
P/B ratio:
6.99%
Volume:
25.9K
Avg. volume:
46.5K
1-year change:
-8.31%
Market cap:
$532.3M
Revenue:
$65.6M
EPS:
$1.41
How Much Does iRadimed Make?
Is iRadimed Growing As A Company?
iRadimed Stock Price Performance
What Is iRadimed 52-Week High & Low?
iRadimed Price To Free Cash Flow
-
Is iRadimed Stock Overvalued?
iRadimed is trading at a price to free cash flow ratio of 49.69 -
Is iRadimed Stock Undervalued?
iRadimed EV to Free Cash Flow ratio is 45.22 -
What Is iRadimed’s Price Earnings Growth Ratio?
IRMD PEG ratio is 1.02 -
Is iRadimed Trading At A Premium To Earnings?
iRadimed EV to EBIT ratio is 23.45
Is It Risky To Buy iRadimed?
Is iRadimed Cash Flow Positive?
iRadimed Return On Invested Capital
iRadimed Earnings Date & Stock Price
-
What Is iRadimed's Stock Price Today?
A single share of IRMD can be purchased today for 42.03 -
What Is iRadimed’s Stock Symbol?
iRadimed trades on the nasdaq under the ticker symbol: IRMD -
When Is iRadimed’s Next Earnings Date?
The next quarterly earnings date for iRadimed is scheduled on August 2, 2024 -
When Is IRMD's next ex-dividend date?
iRadimed's next ex-dividend date is May 17, 2024 -
How To Buy iRadimed Stock?
You can buy iRadimed shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
iRadimed Competitors
iRadimed Dividend Yield
-
What Is IRMD Dividend Yield?
iRadimed’s dividend yield currently is 0.71% -
What Is iRadimed’s Payout Ratio?
iRadimed’s payout ratio is 44.5% -
When Did iRadimed Last Pay A Dividend?
The latest dividend pay date is May 19, 2024 -
What Is iRadimed’s Dividend Per Share?
iRadimed pays a dividend of $0.00 per share
iRadimed Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 18.52% | 7.46% |
Revenue: | 13.72% | 2.73% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 62.50 |
Upside from Last Price: | 48.7% |